生命科学资讯

Appointments and advancements for Jan. 14, 2026

Financings for Jan. 14, 2026

In the clinic for Jan. 14, 2026

Other news to note for Jan. 14, 2026

Regulatory actions for Jan. 14, 2026

Lilly, chasing Novo, expects second-quarter FDA decision on obesity pill

Thermo Fisher Scientific launches new Niton XL5e Analyzer - International Mining

#JPM26: Drugmakers want US reforms, not to slow down China

ImmunityBio's Anktiva lung cancer data; Glaukos' glaucoma implant sales disappoint

JPM26: Leo Pharma, hungry for more partnerships, looks to widen reach in rare dermatology diseases

JPM26: Illumina working with China on 'a path through' its export troubles, sees academic research environment 'muted' for '26

Caldera launches with $112M, former Morphic CEO and IBD drug from China

JPM26, Day 3: Hundreds attend Biotech CEO Sisterhood meetup

Thermo Fisher to lay off 421 workers as it winds down lab product site in North Carolina

Caldera starts up with $112.5M and a dual-targeting immune drug from China

JPM: Illumina working with China on export troubles, CEO says - Fierce Biotech

Robeco Schweiz AG Boosts Stock Holdings in Waters Corporation $WAT - MarketBeat

Lilly, Novo test direct-to-employer approach that could cut out PBMs and lower costs

Agilent Technologies, Inc. $A Holdings Cut by Robeco Schweiz AG - MarketBeat

Caldera Therapeutics erupts with $112.5M and a China-originated IBD bispecific